MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KL-08-0016456
Hestia Pharma Private Limited
Hestia Pharma Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹13,250
▼ 99% YoY
Net loss · FY 2023
₹8,711
Net margin -65.7%
EBITDA · FY 2023
₹2.14 Lakh
Latest filing
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹14 Lakh
Satisfied ₹14 Lakh
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
About Hestia Pharma Private Limited
Data last updated:
Hestia Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 August 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2010PTC054892. Its GSTIN is 32AACCH9339L1ZB (Kerala).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Theruvath Illath Sharanya and Theke Puthan Veedu Ramesan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2023, the company reported a revenue of ₹13,250, a decline of 99% compared to the previous year. For the same year it recorded a net loss of ₹8,711 (net margin -65.7%) and EBITDA of ₹2.14 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 82% over three years and 69% over five years.
As per MCA filings, the company has open charges of ₹14 Lakh and satisfied charges of ₹14 Lakh on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Hestia Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-08-0016456). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232KA2010PTC054892
Registration Number 054892
Incorporation Date 19 August 2010
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-08-0016456
Recognitions & Rankings of Hestia Pharma
Contact details
Hestia Pharma Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressWard No. 26 B.408 Apoorva Paradise Akshaya Nagar Tc – Paliya Main Road Ramamoorthy Nagar, P.O., Bangalore, Karnataka, India – 560016
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Hestia Pharma Private Limited, buy the company report.
Comprehensive company report
Hestia Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Hestia Pharma is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Hestia Pharma Private Limited, buy the company report.
Financials of Hestia Pharma Private Limited
FY 2024 filings availableHestia Pharma Private Limited reported revenue of ₹13,250 (down 99% YoY) for FY 2023.
Revenue · FY 2023
₹13,250 ▼ 99%
Net loss · FY 2023
₹8,711 margin -65.7%
EBITDA · FY 2023
₹2.14 Lakh
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 99%
3 years · compounded
▼ 82%
5 years · compounded
▼ 69%
EBITDA CAGR growth
1 year
▲ 150%
3 years · compounded
▼ 8%
5 years · compounded
▼ 5%
Revenue has declined at a compounded annual rate (CAGR) of 69% over five years, including a 99% fall in the latest year. EBITDA rose 150% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.14 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8,711 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | -65.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hestia Pharma Private Limited, buy the company report.
Board of directors of Hestia Pharma Private Limited
Hestia Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Theruvath Illath Sharanya | Director | 21 Apr 2023 | 3 Years 6 Months | Current |
| Theke Puthan Veedu Ramesan | Director | 05 Jul 2020 | 6 Years 3 Months | Current |
Auditor
Hestia Pharma Private Limited is audited by M J A & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M J A & ASSOCIATES | FY 2019 | 014731S |
Shareholding
The shareholding of Hestia Pharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Hestia Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹14 Lakh
Satisfied charges
₹14 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Aug 2013 | 10445692 | State Bank of Travancore | ₹14 Lakh | Satisfied |
To see the full charge records of Hestia Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Hestia Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Civil suit | Filed against the company by M/S Theon Pharmaceuticals Ltd | Pending |
To see the full case history of Hestia Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hestia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hestia Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AACCH9339L1ZB | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hestia Pharma Private Limited, buy the company report.
Recent activity
Hestia Pharma Private Limited has 10 board changes on record since 2010: 4 appointments and 6 cessations. The latest: Edavalath Kannoth Anil Kumar ceased to be Director on 07 Jan 2026.
Charges
A charge registered on 19 Aug 2013 via Charge ID 10445692 with State Bank Of Travancore was fully satisfied on 13 Feb 2026.
Ceased
Edavalath Kannoth Anil Kumar ceased to be Director.
Ceased
Rakesh Varikkol ceased to be Director.
AGM
Hestia Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Hestia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Appointed
Edavalath Kannoth Anil Kumar was appointed as Director.
Ceased
Muzhayammanal Binoprabha Prabhakaran ceased to be Managing Director.
Appointed
Theruvath Illath Sharanya was appointed as Director.
Ceased
Joby Mathew ceased to be Director.
Appointed
Theke Puthan Veedu Ramesan was appointed as Director.
Ceased
Theke Puthan Veedu Ramesan ceased to be Additional Director.
Ceased
Nellical Velu Appukuttan Nandakumar ceased to be Director.
3 earlier events are in the company report.
Frequently asked questions
Hestia Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 August 2010 (16+ years old) and is registered under CIN U24232KA2010PTC054892.
Hestia Pharma has 2 current directors:
- Theruvath Illath Sharanya - Director
- Theke Puthan Veedu Ramesan - Director
The latest financial statements of Hestia Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Hestia Pharma is 32AACCH9339L1ZB, registered in Kerala.
The CIN (Corporate Identification Number) of Hestia Pharma is U24232KA2010PTC054892. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hestia Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Hestia Pharma was incorporated on 19 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Bangalore.
Edavalath Kannoth Anil Kumar ceased to be Director on 07 Jan 2026. Rakesh Varikkol ceased to be Director on 07 Jan 2026. Edavalath Kannoth Anil Kumar was appointed as Director on 21 Apr 2023. Hestia Pharma has 10 board changes on record in total.
Yes, Hestia Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-08-0016456).
The registered office of Hestia Pharma is at Ward No. 26 B.408 Apoorva Paradise Akshaya Nagar Tc – Paliya Main Road Ramamoorthy Nagar, P.O., Bangalore, Karnataka, India – 560016.